Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
| ▸ | CD44 | P16070 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL252631 | 0.97 | CYP2A6 (0.43) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL9625686 | 0.94 | CYP2A6 (0.41) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL7882217 | 0.82 | CYP1A2 (0.36) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL377159 | 0.80 | ALDH1A1 (0.37) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL29955866 | 0.80 | ALDH1A1 (0.37) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL11347627 | 0.79 | CYP1A2 (0.33) | CYP1A2ACHETSHRESR1 | |
| Hydrochloric Acid SCHEMBL11808601 | 0.79 | ALDH1A1 (0.35) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL11583476 | 0.77 | ALDH1A1 (0.36) | ALDH1A1TRPA1ATM | |
| SCHEMBL7224776 | 0.77 | GABRA1 (0.50) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL29955758 | 0.77 | ESR1 (0.43) | CYP2A6CYP1A2ACHETSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021499-B2 | Bis(6-methyl-3-sulphophenyl)(2-methylphenyl)phosphine, ammonium salt thereof, and method for producing same | KURARAY CO., LTD. (JP) | 2021-06-01 | — | — | US | disclosed |
| US-20190071460-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | HONDA ERIKO (JP) | 2019-03-07 | — | — | US | disclosed |
| EP-2980093-B1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2019-01-09 | — | — | EP | disclosed |
| EP-2980055-B1 | METHOD FOR PRODUCING 2,7-OCTADIEN-1-OL | KURARAY CO (JP) | 2017-11-15 | — | — | EP | disclosed |
| US-9315433-B2 | Method for producing 2,7-octadien-1-OL | KURARAY CO., LTD. (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20160052948-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2016-02-25 | — | — | US | disclosed |
| US-20160046549-A1 | METHOD FOR PRODUCING 2,7-OCTADIEN-1-OL | KURARAY CO., LTD. (JP) | 2016-02-18 | — | — | US | disclosed |
| EP-2980093-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | Kuraray Co., Ltd. (JP) | 2016-02-03 | — | — | EP | disclosed |
| EP-2980055-A1 | METHOD FOR PRODUCING 2,7-OCTADIEN-1-OL | Kuraray Co., Ltd. (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-5696304-A | REACTING CONJUGATED ALKADIENOL WITH WATER USING PALLADIUM CATALYST IN LOW BOILING REACTION SOLVENT, THEN DISTILLATION | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-12-09 | — | — | US | disclosed |
| EP-0605735-B1 | PROCESS FOR PRODUCING ALKADIENOL | MITSUBISHI CHEM CORP (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5600034-A | HEAT TREATING DIALLYL ETHERS IN PRESENCE OF CATALYST CONTAINING PALLADIUM AND PHOSPHORUS COMPOUNDS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-02-04 | — | — | US | disclosed |
| US-5583271-A | Method for continuously producing alkadienols | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-12-10 | — | — | US | disclosed |
| US-5557016-A | HYDROXYLATION OF CONJUGATED ALKADIENES IN THE PRESENCE OF PALLADIUM CATALYSIS | MITSUBISHI KASEI CORPORATION (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0361304-B1 | Method for producing alkadienols | MITSUBISHI CHEM CORP (JP) | 1996-02-21 | — | — | EP | disclosed |
| EP-0605735-A1 | PROCESS FOR PRODUCING ALKADIENOL | Mitsubishi Chemical Corporation (JP) | 1994-07-13 | — | — | EP | disclosed |
| US-4990698-A | Method for producing alkadienols | MITSUBISHI KASEI CORPORATION (JP) | 1991-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046549-A1 | METHOD FOR PRODUCING 2,7-OCTADIEN-1-OL | TELO2, TERT, PCNA | CYP2A6 1739/4885CYP1A2 563/4885ACHE 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.